Zhengshui L. Xu
Key Laboratory Of Surgery Critical Care And Life Support
Xi'an, China
Xi'an, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Mechanism of miR-129-5p targeting MAP3K13/p-p38 signaling pathway to inhibit macrophage activation to antagonize silicotic fibrosis in mice
Journal: Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases
Published: May 25, 2026
Design, synthesis and antiproliferative activity of oxadiazole derivatives as potent glycogen synthase kinase-3/histone deacetylase 6 dual inhibitors.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: February 23, 2026
Graphicalized vision-language modeling for comprehensive lung nodule analysis and risk stratification.
Journal: NPJ digital medicine
Published: November 11, 2025
PPP4C restores YAP1 activity by modulating MST4 phosphorylation to enhance immunosuppression and augment tumor growth in non-small cell lung cancer.
Journal: Cancer letters
Published: October 30, 2025
Advancements and challenges in CAR-NK cell therapy for cancer treatment.
Journal: Trends in biotechnology
Published: August 08, 2025
Association between oxidative balance score and gallstone in US adults: a cross-sectional study.
Journal: Frontiers in aging
Published: May 08, 2025
Comprehensive analysis of single-cell and bulk RNA sequencing data reveals an EGFR signature for predicting immunotherapy response and prognosis in pan-cancer.
Journal: Frontiers in immunology
Published: April 01, 2025
Immune cells mediate the association between the plasma lipidome and pancreatic cancer: a Mendelian randomization analysis.
Journal: Scientific reports
Published: October 09, 2024
Design and synthesis of triazolopyridine derivatives as potent JAK/HDAC dual inhibitors with broad-spectrum antiproliferative activity.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: October 08, 2024
Commentary on "Analysis of Circulating Tumor DNA Predicts Outcomes of Short-Course Consolidation Immunotherapy in Unresectable Stage III NSCLC".
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: August 08, 2024
Last Updated: 09/26/2026